Menta Capital’s Bristol-Myers Squibb BMY Stock Holding History

Menta Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$952K	Buy	20,984 +7,494	+56%	+$349K	0.4%	67
2019 Q1	$644K	Sell	13,490 -9,756	-42%	-$486K	0.28%	124
2018 Q4	$1.21M	Buy	+23,246	New	+$1.25M	0.45%	35
2018 Q3	–	Sell	-11,802	Closed	-$653K	–	560
2018 Q2	$653K	Buy	+11,802	New	+$637K	0.15%	252
2017 Q1	–	Sell	-32,599	Closed	-$1.91M	–	814
2016 Q4	$1.91M	Buy	+32,599	New	+$1.78M	0.16%	203

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Menta Capital's BMY Position: Q2 2019 in Review

Menta Capital increased its Bristol-Myers Squibb (BMY) stake by 56% in Q2 2019, buying an estimated $349K and bringing the position to 20,984 shares worth $952K. The position accounts for 0.4% of the portfolio, ranked #67.

Menta Capital first reported a position in BMY in Q4 2016 and has held it in 5 quarters since. The position peaked at $1.91M in Q4 2016. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Menta Capital held 20,984 shares of Bristol-Myers Squibb worth $952K as of Q2 2019.
Menta Capital bought 7,494 Bristol-Myers Squibb shares in Q2 2019, an estimated $349K.
Bristol-Myers Squibb made up 0.4% of Menta Capital's portfolio in Q2 2019, its #67 holding.
Menta Capital first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 5 quarters since.
Menta Capital's Bristol-Myers Squibb position peaked at $1.91M in Q4 2016.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.